Australia markets closed

Yunkang Group Limited (2325.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
10.9000.000 (0.00%)
At close: 04:08PM HKT
Full screen
Previous close10.900
Open11.000
Bid10.880 x N/A
Ask10.900 x N/A
Day's range10.880 - 11.000
52-week range10.040 - 14.880
Volume56,000
Avg. volume118,643
Market cap6.607B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.190
Earnings dateN/A
Forward dividend & yield0.02 (0.18%)
Ex-dividend date04 July 2024
1y target est14.28
  • PR Newswire

    Yunkang Group participated in S&P Global CSA for the first time Ranks above 89% of participating global peers

    Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its score in the "S&P Global Corporate Sustainability Assessment" ("S&P Global CSA").

  • PR Newswire

    Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million

    Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year ended December 31, 2023 (the "Reporting Period"). In 2023, the Group continued to expand its business network and services across the country, the Group's revenue reached RMB891.5 million. The Group's routine testing business achieved a healthy and steady year-on-year growth of 26.9% during the Reporting Period. Due to enhanced